Study Summary
This trial will study whether a higher dose of CBT-I is more effective in treating cancer-related fatigue than the standard dose.
- Chronic Insomnia
- Cancer-Related Syndrome
- Cancer
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
4 Primary · 0 Secondary · Reporting Duration: Baseline to End of Treatment (Up to 12 weeks)
Trial Safety
Phase-Based Safety
Side Effects for
Awards & Highlights
Trial Design
4 Treatment Groups
Eight Sessions of CBT-I
1 of 4
Ten Sessions of CBT-I
1 of 4
Four Sessions of CBT-I
1 of 4
Twelve Sessions of CBT-I
1 of 4
Experimental Treatment
70 Total Participants · 4 Treatment Groups
Primary Treatment: Cognitive Behavioral Therapy for Insomnia · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 25 - 85 · Female Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is geriatric care being offered to those over 65 years of age in this trial?
"The guidelines for this clinical trial stipulate that the minimum age to participate is 25 and the maximum age is 85." - Anonymous Online Contributor
What criteria must an individual satisfy to be eligible for this trial?
"Through this clinical trial, 70 people aged between 25 and 85 with cancer are being enrolled. In order to participate in the study, candidates must meet the following criteria: A diagnosis of organ-confined BC; Consent for participation; Suffering from insomnia and CRF as indicated by ISI, PROMIS 7a and FACIT-F scores; Being free from any significant medical (e.g., OSA) or psychiatric conditions (e.g., PTSD); RT treatment completed prior to enrollment." - Anonymous Online Contributor
Are there still available slots for individuals looking to join this research experiment?
"Based on clinicaltrials.gov, this scientific experiment is no longer actively searching for participants. First posted on 2/1/2023 and last updated on 10/31/2022, the study has closed its doors to potential candidates; however, there are 2808 other trials currently recruiting patients across the world." - Anonymous Online Contributor